Our Team
At the core of Medicenna is a team with decades of experience creating medicines and creating value, with a passion for cutting-edge science and developing medicines for patients with the highest unmet needs.
Board of Directors
Strategic governance and oversight
Fahar Merchant, PhD
Chair, President and CEO"Dr. Merchant is a biotech veteran with 30 years of experience as a serial entrepreneur and co-founder of Medicenna. Previously he was President and CEO of Protox Therapeutics Inc. where he transitioned a pre-clinical sta..."
Albert G. Beraldo, CPA, CA
Lead Director, Audit Committee"Mr. Beraldo, CPA, CA, has over 30 years' experience in varying roles within the pharmaceutical/biotechnology industry. Mr. Beraldo has been the President of Idoman Limited since July 2008, a company dedicated to improvin..."
Dr. John (Jack) Geltosky, Ph.D.
Audit Committee, Compensation Committee"Dr. Geltosky is currently Managing Director of JEG and Associates, LLC, a business development consulting firm focused on biotech and pharmaceuticals, a position he has held since September 2011. Dr. Jack Geltosky is an ..."
Karim Lalji, MS
Audit Committee, Compensation Committee"Mr. Lalji began his career with Merck & Company at their world headquarters in New Jersey. During his 10-year tenure at Merck, he held several positions of increasing responsibilities, eventually driving global strategie..."
Richard Sutin
Corporate Governance and Nominating Committee"Richard (Rick) Sutin provides corporate legal and ancillary business advisory services to early-stage businesses. From 1983 to December 2018, he was a senior partner at Norton Rose Fulbright where he handled capital mark..."
Angelos Georgakis
Corporate Governance and Nominating Committee"Angelos Georgakis is a strategic advisor to biotech leaders and a long-term supporter of Medicenna. He acts as a close and trusted ally, helping executives become great leaders and navigate their journey of bringing brea..."